Did you submit your info to the MM&M Agency A-to-Z yet?

Share this article:
The deadline for submitting information for your listing in the MM&M Agency A-to-Z has been extended to Wednesday, June 2. Note this deadline is absolute and final, and listings will not be accepted after this date.

The Agency A-to-Z is the definitive annual directory of healthcare agencies and is an editorial important section in MM&M's “Agency Issue,” which publishes in July. More than 140 agencies appeared in last year's A-to-Z.

The information is again being collected via an online survey. Your basic listing is FREE. As in previous years, options are available to enhance your listing with an example of your “best work” and to appear in MM&M's online Agency Gallery. New for 2010 is the ability to upload a video and slide presentation to your online listing. Click Here to submit your information.

For questions about the survey, please contact Lauren Folino at (646) 638-6147 or email lauren.folino@haymarket.com.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...